Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey von Glewis, Sarah, Krishnasamy, Mei, Lingaratnam, Senthil, Harris, Sam, Underhill, Craig, Georgiou, Chloe, Warren, Mark, Campbell, Robert, IJzerman, Maarten, Fagery, Mussab, Campbell, Ian, Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael

Volltext

Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A128) chemotherapies for patients with cancer (PACIFIC‐PGx): A multicenter clinical trial von Glewis, Sarah, Lingaratnam, Senthil, Lee, Benjamin, Campbell, Ian, IJzerman, Maarten, Fagery, Mussab, Harris, Sam, Georgiou, Chloe, Underhill, Craig, Warren, Mark, Campbell, Robert, Jayawardana, Madawa, Silva, S. Sandun M., Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael

Volltext

Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review von Fagery, Mussab, Khorshidi, Hadi A., Wong, Stephen Q., Vu, Martin, IJzerman, Maarten

Volltext

Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial von Glewis, Sarah, Alexander, Marliese, Lingaratnam, Senthil, Lee, Benjamin, Campbell, Ian, Krishnasamy, Mei, IJzerman, Maarten, Fagery, Mussab, Harris, Sam, Georgiou, Chloe, Underhill, Craig, Warren, Mark, Campbell, Robert, Martin, Jennifer, Tie, Jeanne, Michael, Michael

Volltext

Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing von Fagery, Mussab, Khorshidi, Hadi A, Wong, Stephen Q, Karanfil, Özge, Emery, Jon, IJzerman, Maarten J

Volltext